These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15293268)

  • 1. Poison and antidote: a novel model to study pathogenesis and therapy of LHON.
    Manfredi G; Beal MF
    Ann Neurol; 2004 Aug; 56(2):171-2. PubMed ID: 15293268
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.
    Vignal C; Uretsky S; Fitoussi S; Galy A; Blouin L; Girmens JF; Bidot S; Thomasson N; Bouquet C; Valero S; Meunier S; Combal JP; Gilly B; Katz B; Sahel JA
    Ophthalmology; 2018 Jun; 125(6):945-947. PubMed ID: 29426586
    [No Abstract]   [Full Text] [Related]  

  • 3. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile.
    Koilkonda R; Yu H; Talla V; Porciatti V; Feuer WJ; Hauswirth WW; Chiodo V; Erger KE; Boye SL; Lewin AS; Conlon TJ; Renner L; Neuringer M; Detrisac C; Guy J
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7739-53. PubMed ID: 25342621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy.
    Zhang Y; Tian Z; Yuan J; Liu C; Liu HL; Ma SQ; Li B
    Curr Gene Ther; 2017; 17(4):320-326. PubMed ID: 29189152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.
    Rasool N; Lessell S; Cestari DM
    Semin Ophthalmol; 2016; 31(1-2):107-16. PubMed ID: 26959136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.
    Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B
    EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical research progress of gene therapy for Leber hereditary optic neuropathy].
    Wu YJ; Li WS
    Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):636-640. PubMed ID: 30107658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.
    Feuer WJ; Schiffman JC; Davis JL; Porciatti V; Gonzalez P; Koilkonda RD; Yuan H; Lalwani A; Lam BL; Guy J
    Ophthalmology; 2016 Mar; 123(3):558-70. PubMed ID: 26606867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leber hereditary optic neuropathy and oxidative stress.
    Zhuo Y; Luo H; Zhang K
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19882-3. PubMed ID: 23197830
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction and detection of a novel type of recombinant human rAAV2/2-ND4.
    Pei H; Wan X; Hu W; Dong X; Li B
    Eye Sci; 2013 Jun; 28(2):55-9. PubMed ID: 24396955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients.
    Li B; Wu C
    Methods Mol Biol; 2018; 1715():305-311. PubMed ID: 29188523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation.
    Qi X; Sun L; Hauswirth WW; Lewin AS; Guy J
    Arch Ophthalmol; 2007 Feb; 125(2):268-72. PubMed ID: 17296905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leber Hereditary Optic Neuropathy: Exemplar of an mtDNA Disease.
    Wallace DC; Lott MT
    Handb Exp Pharmacol; 2017; 240():339-376. PubMed ID: 28233183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promises and challenges of genetic therapy for blindness.
    Cremers FP; Collin RW
    Lancet; 2009 Nov; 374(9701):1569-70. PubMed ID: 19854500
    [No Abstract]   [Full Text] [Related]  

  • 15. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leber's hereditary optic neuropathy].
    Hilo W; Jabaly-Habib H; Modi N; Briscoe D
    Harefuah; 2013 Aug; 152(8):486-9, 498, 497. PubMed ID: 24167936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDUFA-1 is not a nuclear modifier gene in Leber hereditary optic neuropathy.
    Yu-Wai-Man P; Brown DT; Wehnert MS; Zeviani M; Carrara F; Turnbull DM; Chinnery PF
    Neurology; 2002 Jun; 58(12):1861-2. PubMed ID: 12084895
    [No Abstract]   [Full Text] [Related]  

  • 18. Lentiviral vectors containing a retinal pigment epithelium specific promoter for leber congenital amaurosis gene therapy. Lentiviral gene therapy for LCA.
    Bemelmans AP; Kostic C; Hornfeld D; Jaquet M; Crippa SV; Hauswirth WW; Lem J; Wang Z; Schorderet DE; Munier FL; Wenzel A; Arsenijevic Y
    Adv Exp Med Biol; 2006; 572():247-53. PubMed ID: 17249581
    [No Abstract]   [Full Text] [Related]  

  • 19. Leber Hereditary Optic Neuropathy: A Mitochondrial Disease Unique in Many Ways.
    Bi R; Logan I; Yao YG
    Handb Exp Pharmacol; 2017; 240():309-336. PubMed ID: 27787713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial.
    Cwerman-Thibault H; Augustin S; Ellouze S; Sahel JA; Corral-Debrinski M
    C R Biol; 2014 Mar; 337(3):193-206. PubMed ID: 24702846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.